Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Black

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Vaccine|October 30, 2016
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancyChristine E Jones, Flor M Munoz, Sonali Kochhar, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccineSteven Black, Eric K France, Daniel Isaacman, et al.
Human Vaccines & Immunotherapeutics|July 17, 2013
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the futureJohan Holst, Philipp Oster, Richard Arnold, et al.
The Pediatric Infectious Disease Journal|March 2, 2010
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organizationNicola P Klein, John Hansen, Edwin Lewis, et al.
Circulation|February 7, 2007
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in miceWanpen Vongpatanasin, Gail D Thomas, Randall Schwartz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2005
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?Kurt Reifenberg, Hans-Anton Lehr, Daniela Baskal, et al.
Vaccine|August 7, 2017
Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiativeChristine Guillard-Maure, Varalakshmi Elango, Steven Black, et al.
Vaccine|August 27, 2013
Epidemiology of Group B Streptococcus in developing countriesAtul Kumar Johri, Hem Lata, Puja Yadav, et al.
BMC Pediatrics|November 15, 2006
Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth doseNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
The Pediatric Infectious Disease Journal|February 16, 2021
VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of GonorrheaLaura M Reyes Díaz, Miriam de S J B Lastre González, Maribel Cuello, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Vaccine|October 30, 2016
Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancyChristine E Jones, Flor M Munoz, Sonali Kochhar, et al.
The Pediatric Infectious Disease Journal|August 28, 2007
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccineSteven Black, Eric K France, Daniel Isaacman, et al.
Human Vaccines & Immunotherapeutics|July 17, 2013
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the futureJohan Holst, Philipp Oster, Richard Arnold, et al.
The Pediatric Infectious Disease Journal|March 2, 2010
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organizationNicola P Klein, John Hansen, Edwin Lewis, et al.
Circulation|February 7, 2007
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in miceWanpen Vongpatanasin, Gail D Thomas, Randall Schwartz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2005
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?Kurt Reifenberg, Hans-Anton Lehr, Daniela Baskal, et al.
Vaccine|August 7, 2017
Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiativeChristine Guillard-Maure, Varalakshmi Elango, Steven Black, et al.
Vaccine|August 27, 2013
Epidemiology of Group B Streptococcus in developing countriesAtul Kumar Johri, Hem Lata, Puja Yadav, et al.
BMC Pediatrics|November 15, 2006
Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth doseNancy D Lin, Ken Kleinman, K Arnold Chan, et al.
The Pediatric Infectious Disease Journal|February 16, 2021
VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of GonorrheaLaura M Reyes Díaz, Miriam de S J B Lastre González, Maribel Cuello, et al.
Pageof 15